Statistics
Publications
3
Citations
2.7K
H-Index
3
Active since
2018
Affiliations
University of Münster(Current)
Kenneth Sharlin is an author at University of Münster specializing in cognitive neurology, cognitive impairment, and monoclonal antibody therapy.
Publications per year
2018–2023
3
3
Donanemab in Early Symptomatic Alzheimer Disease
John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text
Medicine, Neurology, Neuroscience +17
Reversal of Cognitive Decline: 100 Patients
Dale E. Bredesen, Kenneth Sharlin, David Jenkins et al. · Journal of Alzheimer’s Disease & Parkinsonism · 2018 · 42 citations · Full text
1–3 of 3